Health Economics

Health systems worldwide are confronted by the need to reduce costs -
or avoid them altogether.

The findings of recent studies, particularly those of Frat1 and Hernández2, provide strong justification for the use of Optiflow™ both pre-intubation and post-extubation, as a means to reduce escalation and to avoid its associated costs.

Use Optiflow™ to reduce escalation

A patient's journey through hospital may include periods of escalation and de-escalation of care. Consider this conceptual model, at left, showing two patients' journeys through hospital. The costs for these journeys are denoted by the areas of blue and red.

Using Optiflow™ as a first-line treatment (both pre-intubation and post-extubation) may reduce a patient's escalation "up the acuity curve", resulting in better patient outcomes and reduced costs of care.

We call this Optiflow™ FIRST.

Clinical Evidence

NHF significantly reduced need for intubation in more acute patients

(compared to standard O2 and NIV, PaO2:FiO2 ≤ 200 mmHg)

~ Frat et al. New Engl J Med. 2015.

‘Use of [NHF] reduced the risk of reintubation within 72 hours.’

(among extubated patients at low risk of reintubation)

~ Hernández. et al. JAMA. 2016.

‘Use of NHF is associated with a lower reintubation rate.’

~ Maggiore et al. Am J Respir Crit Care Med. 2014.